Clinical Trials Study
Copyright ©The Author(s) 2016.
World J Gastrointest Pathophysiol. Feb 15, 2016; 7(1): 160-170
Published online Feb 15, 2016. doi: 10.4291/wjgp.v7.i1.160
Table 1 Comparison of baseline characteristics of randomized patients in the two study groups
LGG+ groupLGG- group
Continuous variablesnmean ±SDnmean ± SDP
Age at the time randomized (d)957 ± 301168 ± 280.341
Gestational age (wk)938 ± 21137 ± 20.201
Birth weight (kg)93.1 ± 0.8112.9 ± 1.10.471
Birth height (cm)751.6 ± 1.8947.2 ± 5.30.041
Discrete variablesnmean ± SDnmean ± SD
Gender911
Female4 (44.4)4 (36.4)1.0
Male5 (55.6)7 (63.6)
Race9111.0
African-american3 (33.3)4 (36.4)
Caucasian6 (66.7)7 (63.6)
Ethnicity9111.0
Hispanic or latino2 (22.2)2 (18.2)
Not hispanic or latino7 (77.8)9 (81.8)
Partial breast feed9111.0
Yes3 (33.3)3 (27.3)
No6 (66.7)8 (72.7)
Formula type911
Earth’s best1 (11.1)0 (0)
Enfamil1 (11.1)0 (0)
Enfamil gentleease1 (11.1)0 (0)
Gerber good start0 (0)1 (9.1)
Isomil1 (11.1)1 (9.1)
Neocate0 (0)1 (9.1)
Nutramigen ready mix0 (0)1 (9.1)
Similac2 (22.2)0 (0)
Similac advance1 (11.1)0 (0)
Similac senstive0 (0)5 (45.5)
Breast milk2 (22.2)2 (18.2)
Table 2 Longitudinal analysis of clinical variables by study group (LGG+ vs LGG-) at baseline and follow up visits
Adjusted means (95%CI)
P value
LGG+ groupLGG- groupMean differences(95%CI)
Crying + fussing time (min)
Visit 1 (Baseline)296 (210, 381)337 (251, 422)41 (-80, 161)0.51
Visit 2197 (117, 278)289 (142, 436)91 (-76, 259)0.29
Visit 3144 (54, 234)199 (69, 328)55 (-104, 213)0.50
Visit 4111 (65, 157)133 (60, 205)22 (-64, 107)0.62
Fecal calprotectin (μg/g)
Visit 1 (Baseline)285 (199, 371)294 (184, 404)9 (-131, 149)0.90
Visit 2226 (182, 270)305 (186, 423)79 (-48, 205)0.22
Visit 3229 (113, 345)250 (154, 347)21 (-130, 172)0.78
Visit 4211 (80, 342)332 (225, 440)121 (-48, 291)0.16
Table 3 Longitudinal analysis of cytokins by study group (LGG+ vs LGG-) at baseline and follow up visits
Adjusted geometric means (95%CI)
P
LGG+ groupLGG- group
Cytokines
IFN-γ (pg/mL)
Visit 1 (Baseline)0.7 (0.4, 1.3)0.6 (0.3, 1.2)0.84
Visit 21.2 (0.7, 2.0)0.5 (0.3, 0.9)0.04
Visit 40.4 (0.3, 0.6)0.2 (0.1, 0.4)0.07
IL-10 (pg/mL)
Visit 1 (Baseline)3.7 (2.3, 6.0)4.2 (2.2, 8.1)0.78
Visit 24.3 (3.2, 5.7)3.8 (2.3, 6.4)0.72
Visit 42.7 (1.7, 4.2)2.0 (1.1, 3.7)0.47
IL-12p70 (pg/mL)
Visit 1 (Baseline)0.2 (0.1, 0.4)0.2 (0.1, 0.4)0.85
Visit 20.3 (0.2, 0.4)0.4 (0.3, 0.6)0.29
Visit 40.2 (0.1, 0.5)0.3 (0.2, 0.4)0.57
IL-1β (pg/mL)
Visit 1 (Baseline)0.08 (0.05, 0.13)0.19 (0.08, 0.43)0.09
Visit 20.27 (0.08, 0.88)0.15 (0.06, 0.40)0.45
Visit 40.11 (0.05, 0.21)0.16 (0.05, 0.49)0.52
IL-6 (pg/mL)
Visit 1 (Baseline)0.3 (0.2, 0.5)0.4 (0.3, 0.6)0.36
Visit 20.3 (0.2, 0.6)0.3 (0.2, 0.4)0.66
Visit 40.2 (0.1, 0.4)0.2 (0.1, 0.3)0.63
IL-8 (pg/mL)
Visit 1 (Baseline)6.5 (4.8, 8.7)7.0 (5.3, 9.4)0.69
Visit 25.4 (4.1, 7.3)9.5 (6.6, 13.7)0.02
Visit 44.9 (3.2, 7.5)4.6 (2.8, 7.8)0.88
TNF-α (pg/mL)
Visit 1 (Baseline)4.5 (3.8, 5.3)4.8 (3.7, 6.2)0.69
Visit 25.4 (4.4, 6.5)4.2 (3.2, 5.5)0.15
Visit 44.4 (3.3, 5.9)5.7 (4.7, 6.9)0.14
Treg (%)
Visit 1 (Baseline)7.2 (6.5, 8.0)6.7 (5.9, 7.5)0.37
Visit 27.5 (6.8, 8.2)8.5 (7.0, 10.3)0.23
Visit 47.5 (6.1, 9.3)9.2 (8.1, 10.5)0.10

  • Citation: Fatheree NY, Liu Y, Ferris M, Van Arsdall M, McMurtry V, Zozaya M, Cai C, Rahbar MH, Hessabi M, Vu T, Wong C, Min J, Tran DQ, Navarro F, Gleason W, Gonzalez S, Rhoads JM. Hypoallergenic formula with Lactobacillus rhamnosus GG for babies with colic: A pilot study of recruitment, retention, and fecal biomarkers. World J Gastrointest Pathophysiol 2016; 7(1): 160-170
  • URL: https://www.wjgnet.com/2150-5330/full/v7/i1/160.htm
  • DOI: https://dx.doi.org/10.4291/wjgp.v7.i1.160